Pembrolizumab vs Telmisartan

## Pembrolizumab vs Telmisartan: Overview

This comparison examines the pharmacological differences between **Pembrolizumab** and **Telmisartan**.

## Mechanism of Action

**Pembrolizumab**: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

**Telmisartan**: Selective angiotensin II type 1 receptor antagonist; also a partial PPAR-gamma agonist.

## Pharmacokinetics

**Half-life**: Pembrolizumab — 26 days; Telmisartan — 24 hours.

## Chemical Properties

**Molecular Formula**: Pembrolizumab — N/A; Telmisartan — C33H30N4O2.

**Molecular Weight**: Pembrolizumab — N/A; Telmisartan — 514.6230 g/mol.

**Type**: Pembrolizumab — Antibody; Telmisartan — Small molecule.